Carasent ASA (CARA) - Total Liabilities
Based on the latest financial reports, Carasent ASA (CARA) has total liabilities worth Skr141.85 Million SEK (≈ $15.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Carasent ASA - Total Liabilities Trend (2002–2025)
This chart illustrates how Carasent ASA's total liabilities have evolved over time, based on quarterly financial data. See Carasent ASA short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Carasent ASA Competitors by Total Liabilities
The table below lists competitors of Carasent ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korro Bio, Inc.
NASDAQ:KRRO
|
USA | $63.99 Million |
|
Maeil Dairies Co. Ltd
KQ:267980
|
Korea | ₩434.83 Billion |
|
Megaforce Co Ltd
TWO:3294
|
Taiwan | NT$2.57 Billion |
|
Lin Horn Technology Co Ltd
TWO:5464
|
Taiwan | NT$3.26 Billion |
|
HUYA Inc
NYSE:HUYA
|
USA | $1.78 Billion |
|
KABE Group AB (publ.)
ST:KABE-B
|
Sweden | Skr1.00 Billion |
|
Aurum PropTech Limited
NSE:AURUM
|
India | Rs4.14 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Carasent ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Carasent ASA market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carasent ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carasent ASA (2002–2025)
The table below shows the annual total liabilities of Carasent ASA from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr133.00 Million ≈ $14.31 Million |
-25.87% |
| 2024-12-31 | Skr179.42 Million ≈ $19.31 Million |
+29.79% |
| 2023-12-31 | Skr138.24 Million ≈ $14.88 Million |
-4.20% |
| 2022-12-31 | Skr144.30 Million ≈ $15.53 Million |
+11.39% |
| 2021-12-31 | Skr129.54 Million ≈ $13.94 Million |
+24.59% |
| 2020-12-31 | Skr103.97 Million ≈ $11.19 Million |
+125.62% |
| 2019-12-31 | Skr46.08 Million ≈ $4.96 Million |
+65.70% |
| 2018-12-31 | Skr27.81 Million ≈ $2.99 Million |
+5362.63% |
| 2017-12-31 | Skr509.11K ≈ $54.79K |
-58.23% |
| 2016-12-31 | Skr1.22 Million ≈ $131.17K |
-99.17% |
| 2015-12-31 | Skr146.11 Million ≈ $15.72 Million |
-0.13% |
| 2014-12-31 | Skr146.30 Million ≈ $15.74 Million |
+56.42% |
| 2013-12-31 | Skr93.53 Million ≈ $10.07 Million |
-4.31% |
| 2012-12-31 | Skr97.74 Million ≈ $10.52 Million |
+13.48% |
| 2011-12-31 | Skr86.13 Million ≈ $9.27 Million |
-4.00% |
| 2010-12-31 | Skr89.72 Million ≈ $9.66 Million |
+23.23% |
| 2009-12-31 | Skr72.80 Million ≈ $7.83 Million |
-27.34% |
| 2008-12-31 | Skr100.19 Million ≈ $10.78 Million |
-1.07% |
| 2007-12-31 | Skr101.28 Million ≈ $10.90 Million |
+10.80% |
| 2006-12-31 | Skr91.40 Million ≈ $9.84 Million |
+28.75% |
| 2005-12-31 | Skr70.99 Million ≈ $7.64 Million |
+432.33% |
| 2004-12-31 | Skr13.34 Million ≈ $1.44 Million |
+97.92% |
| 2003-12-31 | Skr6.74 Million ≈ $725.12K |
-5.33% |
| 2002-12-31 | Skr7.12 Million ≈ $765.90K |
-- |
About Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more